Prot #GR40550/RO4893594: A Phase III, Multicenter, Randomized Visual Assesor-Masked, Active-Comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System with Ranibizumab in Patients with Diabetic Macular Edema (PAGODA)